385 related articles for article (PubMed ID: 16736524)
1. Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice.
Cho SG; Min SY; Park MJ; Lee KW; Cho YG; Cho ML; Chang HS; Park SH; Lee JW; Min WS; Kim CC; Kim HY
Arthritis Rheum; 2006 Jun; 54(6):1878-87. PubMed ID: 16736524
[TBL] [Abstract][Full Text] [Related]
2. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
3. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
[TBL] [Abstract][Full Text] [Related]
5. Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor alpha, interleukin-1beta, and interleukin-8 from peripheral blood monocytes via Fc gamma receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis.
Mullazehi M; Mathsson L; Lampa J; Rönnelid J
Arthritis Rheum; 2006 Jun; 54(6):1759-71. PubMed ID: 16736518
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
[TBL] [Abstract][Full Text] [Related]
8. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase.
Ross AD; Banda NK; Muggli M; Arend WP
Arthritis Rheum; 2004 Nov; 50(11):3702-11. PubMed ID: 15529385
[TBL] [Abstract][Full Text] [Related]
10. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist.
Nakae S; Saijo S; Horai R; Sudo K; Mori S; Iwakura Y
Proc Natl Acad Sci U S A; 2003 May; 100(10):5986-90. PubMed ID: 12721360
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice.
Koenders MI; Devesa I; Marijnissen RJ; Abdollahi-Roodsaz S; Boots AM; Walgreen B; di Padova FE; Nicklin MJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2008 Nov; 58(11):3461-70. PubMed ID: 18975337
[TBL] [Abstract][Full Text] [Related]
12. CD28-dependent differentiation into the effector/memory phenotype is essential for induction of arthritis in interleukin-1 receptor antagonist-deficient mice.
Kotani M; Hirata K; Ogawa S; Habiro K; Ishida Y; Tanuma S; Horai R; Iwakura Y; Kishimoto H; Abe R
Arthritis Rheum; 2006 Feb; 54(2):473-81. PubMed ID: 16453283
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
14. Involvement of tumor necrosis factor-alpha in the development of T cell-dependent aortitis in interleukin-1 receptor antagonist-deficient mice.
Matsuki T; Isoda K; Horai R; Nakajima A; Aizawa Y; Suzuki K; Ohsuzu F; Iwakura Y
Circulation; 2005 Aug; 112(9):1323-31. PubMed ID: 16129814
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
[TBL] [Abstract][Full Text] [Related]
17. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production.
Lo CK; Lam QL; Sun L; Wang S; Ko KH; Xu H; Wu CY; Zheng BJ; Lu L
Arthritis Rheum; 2008 Sep; 58(9):2700-11. PubMed ID: 18759269
[TBL] [Abstract][Full Text] [Related]
19. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy.
Triantaphyllopoulos KA; Williams RO; Tailor H; Chernajovsky Y
Arthritis Rheum; 1999 Jan; 42(1):90-9. PubMed ID: 9920019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]